Kevin Patrick Danahy - 14 Feb 2022 Form 3 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role: Chief Commercial Officer
Signature: /s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol: PLSE
Transactions as of: 14 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 22 Mar 2022, 16:10:33 UTC
Next filing: 24 Mar 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney